Tetramer Citations

HLA-A*02:01 Citations

Product CodeAllelePublication
TB-0008-1TB-0008-2, TB-0008-4HLA-A*02:01 HIV pol Tetramer-ILKEPVHGVShacklett BL, et al. J Virol 77: 5621-5631 (2003, BCI) 
Harari A, et al. J Virol 83: 2862-2871 (2009 BCI)
Cellerai C, et al. J Virol 84: 3868–3878 (2010 BCI)
TB-0009-1HLA-A*02:01 Mart-1 Tetramer-PEMantovani S, et al. J Immunol 169: 6253-6260 (2002 BCI) 
Paczesny S, et al. J Exp Med 199: 1503-1511 (2004 BCI)
Coughlin CM, et al. Blood 103: 2046-2054 (2004 BCI)
Tomiyama M, et al. Anticancer Res. 24: 3327-3334 (2004, MBL)
Akiyama Y, et al. J. Transl. Med. 3: 4-13 (2005)
Casati C, et al. Cancer Res 66: 4450-4460 (2006 BCI)
Sasawatari S, et al. Immunol Cell Biol 84: 512–521 (2006, MBL)
Wong RM, et al. Int Immunol 19: 1223-1234 (2007 BCI) 
Takahara M, et al. J. Leukoc. Biol. 83: 742-754 (2008)
Frleta D, et al. J. Immunol 182: 2766-2776 (2009 BCI) 
Alanio C, et al. Blood 115: 3718-3725 (2010 BCI)
Banchereau J, et al. PNAS 109: 18885-18890 (2012 BCI) 
Bruns H, et al. Clin Cancer Res 21: 2075-2083 (2015, BCI) 
McCracken MN, et al. J Clin Invest 125: 1815–1826 (2015, MBL)
TB-0010-1TB-0010-2HLA-A *02:01 CMV pp65 Tetramer-NLVPMVATV Shacklett BL, et al. J Virol 77: 5621-5631 (2003, BCI)
Aandahl EM, et al. J Immunol 170: 2349-2355 (2003 BCI)
Betts MR, et al. J Immunol 172: 6407-6417 (2004, BCI) 
Paczesny S, et al. J Exp Med 199: 1503-1511 (2004 BCI)
Morita Y, et al. Bone Marrow Transplant 36: 803-811 (2005)
Komatsu H, et al. Immun Ageing 3: 11 (2006)
Comin-Anduix B, et al. Clin Cancer Res 12: 107-116 (2006, BCI) 
Zhang H, et al. J Immunol 179: 4910-4918 (2007 BCI) 
Sabouri AH, et al. Blood 112: 2411-2420 (2008)
Watanabe K, et al. Int J Hematol. 88: 311-320 (2008) 
Walker EB, et al. Clin. Cancer Res 14: 5270-5283 (2008 BCI) 
Harari A, et al. J Virol 83: 2862-2871 (2009 BCI) 
Cellerai C, et al. J Virol 84: 3868–3878 (2010 BCI)
Alanio C, et al. Blood 115: 3718-3725 (2010 BCI)
Takamori A, et al. Retrovirology 8: 100 (2011)
Odumade OA, et al. J Exp Med 209: 471-478 (2012 BCI)
Ezinne CC, et al. PLoS One 9: e87631 (2014) 
Nakauchi Y, et al. Exp Hematol 43: 79–88 (2015, MBL) 
TB-0011-1TB-0011-2HLA-A*02:01 EBV BMLF1 Tetramer-GLCTLVAML Tomiyama M, et al. Anticancer Res. 24: 3327-3334 (2004)
Sasawatari S, et al. Immunol Cell Biol 84: 512–521 (2006, MBL)
Turtle CJ, et al. Immunity 31: 834-844 (2009 BCI)
Harari A, et al. J Virol 83: 2862-2871 (2009 BCI) 
Shultz LD, et al. PNAS 107: 13022-13027 (2010)
Cellerai C, et al. J Virol 84: 3868–3878 (2010 BCI)
Odumade OA, et al. J Exp Med 209: 471-478 (2012 BCI) 
Faustman DL, et al. PLoS One 7: e41756 (2012, BCI) 
Kobayashi E, et al. Nature Med 19: 1542–1546 (2013)
Ezinne CC, et al. PLoS One 9: e87631 (2014) 
Sasawatari S, et al. Immunol Cell Biol 84: 512–521 (2006, MBL) 
TB-0012-1TB-0012-2TB-0012-4 HLA-A*02:01 Influenza M1 Tetramer GILGFVFTL Mantovani S, et al. J Immunol 169: 6253-6260 (2002 BCI) 
Aandahl EM. et al. J. Immunol. 170: 2349-2355 (2003 BCI)
Paczesny S, et al. J Exp Med 199: 1503-1511 (2004 BCI)
Coughlin CM, et al. Blood 103: 2046-2054 (2004 BCI)
Hess C, et al. Blood 104: 3463-3471 (2004 BCI) 
Aandahl EM, et al. Blood 104: 3672-3678 (2004 BCI) 
Akiyama Y, et al. J. Transl. Med. 3: 4-13 (2005)
Moran TP, et al. J Immunol 175: 3431-3438 (2005 BCI) 
Cooper LJN, et al. Blood 105: 1622-1631 (2005 BCI)
Yang S, et al. Clin Cancer Res 11: 5603-5615 (2005 BCI)
Naumov YN, et al. J Immunol 177: 2006-2014 (2006 BCI)
Casati C. et al. Cancer Res. 66: 4450-4460 (2006 BCI)
Zhang H, et al. J Immunol 179: 4910-4918 (2007 BCI)
Naumov YN, et al. J Immunol 181: 7407-7419 (2008) 
Walker EB, et al. Clin. Cancer Res 14: 5270-5283 (2008 BCI) 
He X-S, et al. J Infect Dis 197: 803-811 (2008 BCI) 
Yu CI, et al. Blood 112: 3671-3678 (2008 BCI)
Turtle CJ, et al. Immunity 31: 834-844 (2009 BCI) 
Frleta D, et al. J. Immunol 182: 2766-2776 (2009 BCI)
Harari A, et al. J Virol 83: 2862-2871 (2009 BCI) 
Cellerai C, et al. J Virol 84: 3868–3878 (2010 BCI)
Tu W, et al. J Virol 84: 6527-6535 (2010 BCI)
Ndhlovu ZM, et al. PNAS 107: 3669-3674 (2010 BCI)
Alanio C, et al. Blood 115: 3718-3725 (2010 BCI) 
Romano E, et al. Clin Cancer Res 17: 1984-1997 (2011 BCI) 
Odumade OA, et al. J Exp Med 209: 471-478 (2012 BCI) 
Flamar A-L, et al.J Immunol 189: 2645-2655 (2012 BCI) 
Bruns H, et al. Clin Cancer Res 21: 2075-2083 (2015, BCI) 
TB-0013-1TB-0013-2HLA-A*02:01 gp100 (mutant) Tetramer-IMDQVPFSVPaczesny S, et al. J Exp Med 199: 1503-1511 (2004 BCI)
Akiyama Y, et al. J. Transl. Med. 3: 4-13 (2005)
Wong RM, et al. Int Immunol 19: 1223-1234 (2007 BCI) 
Walker EB, et al. Clin. Cancer Res 14: 5270-5283 (2008 BCI)
Frleta D, et al. J. Immunol 182: 2766-2776 (2009 BCI) 
Romano E, et al. Clin. Cancer Res 17: 1984-1997 (2011 BCI)
TB-0014-1TB-0014-2 HLA-A*02:01 gp100 (wild) Tetramer-ITDQVPFSV Walker EB, et al. Clin. Cancer Res 14: 5270-5283 (2008 BCI) 
Chung B, et al. Cell Reports 8: 871-882 (2014 MBLI) 
TB-0015-1TB-0015-2 HLA-A*02:01 Her-2/neu E75 Tetramer-KIFGSLAFL Faustman DL, et al. PLoS One 7: e41756 (2012, BCI)   
TB-0019-4TB-0019-1TB-0019-2HLA-A*02:01 Tyrosinase Tetramer-YMDGTMSQVPaczesny S, et al. J Exp Med 199: 1503-1511 (2004 BCI)
Akiyama Y, et al. J Transl Med 3: 4-13 (2005)
Romano E, et al. Clin Cancer Res 17: 1984-1997 (2011 BCI) 
Mehrotra S, et al. J Immunol 189: 1627-1638 (2012 BCI)
TB-0146-1 HLA-A*02:01 EBV LMP1 Tetramer-PE Kobayashi E, et al. Nature Med 19: 1542–1546 (2013)
Shultz LD, et al. PNAS 107: 13022-13027 (2010) 
TS-M140-1HLA-A*02:01 WT1 TetramerKobayashi M, et al. J Ovarian Res. 7: 48 (2014)
Najima Y, et al. Blood 127: 722-734 (2016, MBL)
TS-M019-1 HLA-A*02:01 HTLV-1 Tax178-186 Tetramer-PE Kozako T, et al. J Immunol 177: 5718-5726 (2006)
Akimoto M, et al. J Med Virol 79: 977-986 (2007)
Sabouri AH, et al. Blood 112: 2411-2420 (2008)
Kozako T, et al. Leukemia 23: 375-382 (2009) 
Tanaka Y, et al. Cancer Res 70: 6181-6192 (2010) 
Takamori A, et al. Retrovirology 8: 100 (2011) 
Kozako T, et al. Hum Immunol 72: 1001-1006 (2011)
Kozako T, et al. J Med Virol 83: 501-509 (2011)
Kozako T, et al. FEBS J 278: 1358–1366 (2011)
Tamai Y, et al. J Immunol 190: 4382-4392 (2013) 
Tezuka K, et al. Blood 123: 346-355 (2014) 
Ezinne CC, et al. PLoS One 9: e87631 (2014)
Matsuura E, et al. J Neuropathol Exp Neurol 74: 2-14 (2015) 
TB-M027-2TB-M027-1TB-M027-4HLA-A*02:01 HIV gag Tetramer-SLYNTVATLKitamura H, et al. Urology 67: 955-959 (2006) 
Tsuruma T, et al. J Transl Med 6: 24 (2008)
Miyazaki A, et al. Cancer Sci. 102: 324-329 (2011)
Kameshima H, et al. Cancer Sci. 102: 1181-1187 (2011)
Kameshima H, et al. Cancer Sci. 104: 124-129 (2013)
Satomi F, et al. Int J Cancer Clin Res 2: 1-6 (2015, MBL)
Tanaka T, et al. Cancer Sci. 106: 18-24 (2015)
Tanaka T, et al. Clin Dev Immunol. 2013;2013:262967. doi: 10.1155/2013/262967

HLA-A*11:01 Citations

Product CodeAllelePublication
TS-M023-1HLA-A*11:01 HTLV-1 Tax88-96 Tetramer KVLTPPITH-PEKozako T, et al. J Immunol 177: 5718-5726 (2006)
Akimoto M, et al. J Med Virol 79: 977-986 (2007)
Sabouri AH, et al. Blood 112: 2411-2420 (2008)
Kozako T, et al. Leukemia 23: 375-382 (2009) 
Tanaka Y, et al. Cancer Res 70: 6181-6192 (2010) 
Takamori A, et al. Retrovirology 8: 100 (2011) 
Kozako T, et al. Hum Immunol 72: 1001-1006 (2011)
Kozako T, et al. J Med Virol 83: 501-509 (2011)
Kozako T, et al. FEBS J 278: 1358–1366 (2011)
Tamai Y, et al. J Immunol 190: 4382-4392 (2013) 
Tezuka K, et al. Blood 123: 346-355 (2014) 
Ezinne CC, et al. PLoS One 9: e87631 (2014)
Matsuura E, et al. J Neuropathol Exp Neurol 74: 2-14 (2015)

HLA-A*24:02 Citations

Product CodeAllelePublication
TS-M001-1HLA-A*24:02 EBV LMP2 Tetramer-IYVLVMLVL-PEWatanabe K, et al. Int J Hematol. 88: 311-320 (2008) 
Kozako T, et al. Leukemia 23: 375-382 (2009) , BRLF1
Sato K, et al. Blood 117: 5663-5673 (2011)
Kobayashi E, et al. Nature Med 19: 1542–1546 (2013)
Ezinne CC, et al. PLoS One 9: e87631 (2014) , BRLF1
TS-M002-1HLA-A*24:02 EBV BRLF1 Tetramer-PEWatanabe K, et al. Int J Hematol. 88: 311-320 (2008) BMLF1
Kozako T, et al. Leukemia 23: 375-382 (2009) , BRLF1
Sato K, et al. Blood 117: 5663-5673 (2011)
Kobayashi E, et al. Nature Med 19: 1542–1546 (2013)
Ezinne CC, et al. PLoS One 9: e87631 (2014) , BRLF1
TS-M003-1HLA-A*24:02 EBV BMLF1 Tetramer-PEWatanabe K, et al. Int J Hematol. 88: 311-320 (2008) BMLF1
Kozako T, et al. Leukemia 23: 375-382 (2009) , BRLF1
Sato K, et al. Blood 117: 5663-5673 (2011)
Kobayashi E, et al. Nature Med 19: 1542–1546 (2013)
Ezinne CC, et al. PLoS One 9: e87631 (2014) , BRLF1
TS-M004-1HLA-A*24:02 EBV EBNA3A Tetramer-PEWatanabe K, et al. Int J Hematol. 88: 311-320 (2008) BMLF1
Kozako T, et al. Leukemia 23: 375-382 (2009) , BRLF1
Sato K, et al. Blood 117: 5663-5673 (2011)
Kobayashi E, et al. Nature Med 19: 1542–1546 (2013)
Ezinne CC, et al. PLoS One 9: e87631 (2014) , BRLF1
TS-M007-3HLA-A*24:02 Negative Tetramer-PEAkiyama Y, et al. J Transl Med 3: 4-13 (2005)
Kozako T, et al. J Immunol 177: 5718-5726 (2006)
Akimoto M, et al. J. Med Virol 79: 977-86 (2007)
Tsuruma T, et al. J Transl Med 6: 24 (2008)
Tsukahara T, et al. Cancer Sci 99: 368-375 (2008)
Kozako T, et al. Leukemia 23: 375-382 (2009) 
Akiyama Y, et al. Anticancer Res 29: 647-655 (2009)
Kameshima H, et al. Cancer Sci 102: 1181-1187 (2011)
Kameshima H, et al. Cancer Sci 104: 124-129 (2013)
Tezuka K, et al. Blood 123: 346-355 (2014)
Koido S, et al. Clin Cancer Res 20: 4228-4239 (2014, MBL) 
Satomi F, et al. Int J Cancer Clin Res 2: 1-6 (2015, MBL)
Tanaka T, et al. Cancer Sci. 106: 18-24 (2015)
Najima Y, et al. Blood 127: 722-734 (2016, MBL)
Murata K et al. OncoImmunology DOI:10.1080/2162402X.2016.1165376
TS-M009-1HLA-A*24:02 EBV Mix Tetramer-PEKobayashi E, et al. Nature Med 19: 1542–1546 (2013)
TS-M010-1HLA-A*24:02 hTERT Tetramer-PEKobayashi E, et al. Nature Med 19: 1542–1546 (2013)
Mizukoshi E, et al. Hepatology 43: 1284-1294 (2006)
TS-M020-1HLA-A*24:02 HTLV-1 Tax12-20 Tetramer-PEKozako T, et al. J Immunol 177: 5718-5726 (2006)
Akimoto M, et al. J Med Virol 79: 977-986 (2007)
Sabouri AH, et al. Blood 112: 2411-2420 (2008)
Kozako T, et al. Leukemia 23: 375-382 (2009) 
Tanaka Y, et al. Cancer Res 70: 6181-6192 (2010) 
Takamori A, et al. Retrovirology 8: 100 (2011) 
Kozako T, et al. Hum Immunol 72: 1001-1006 (2011)
Kozako T, et al. J Med Virol 83: 501-509 (2011)
Kozako T, et al. FEBS J 278: 1358–1366 (2011)
Tamai Y, et al. J Immunol 190: 4382-4392 (2013) 
Tezuka K, et al. Blood 123: 346-355 (2014) 
Ezinne CC, et al. PLoS One 9: e87631 (2014)
Matsuura E, et al. J Neuropathol Exp Neurol 74: 2-14 (2015)
TS-M021-1HLA-A*24:02 HTLV-1 Tax187-195 Tetramer-PEKozako T, et al. J Immunol 177: 5718-5726 (2006)
Akimoto M, et al. J Med Virol 79: 977-986 (2007)
Sabouri AH, et al. Blood 112: 2411-2420 (2008)
Kozako T, et al. Leukemia 23: 375-382 (2009) 
Tanaka Y, et al. Cancer Res 70: 6181-6192 (2010) 
Takamori A, et al. Retrovirology 8: 100 (2011) 
Kozako T, et al. Hum Immunol 72: 1001-1006 (2011)
Kozako T, et al. J Med Virol 83: 501-509 (2011)
Kozako T, et al. FEBS J 278: 1358–1366 (2011)
Tamai Y, et al. J Immunol 190: 4382-4392 (2013) 
Tezuka K, et al. Blood 123: 346-355 (2014) 
Ezinne CC, et al. PLoS One 9: e87631 (2014)
Matsuura E, et al. J Neuropathol Exp Neurol 74: 2-14 (2015)
TS-M022-1HLA-A*24:02 HTLV-1 Env11-19 Tetramer-PEKozako T, et al. J Immunol 177: 5718-5726 (2006)
Akimoto M, et al. J Med Virol 79: 977-986 (2007)
Sabouri AH, et al. Blood 112: 2411-2420 (2008)
Kozako T, et al. Leukemia 23: 375-382 (2009) 
Tanaka Y, et al. Cancer Res 70: 6181-6192 (2010) 
Takamori A, et al. Retrovirology 8: 100 (2011) 
Kozako T, et al. Hum Immunol 72: 1001-1006 (2011)
Kozako T, et al. J Med Virol 83: 501-509 (2011)
Kozako T, et al. FEBS J 278: 1358–1366 (2011)
Tamai Y, et al. J Immunol 190: 4382-4392 (2013) 
Tezuka K, et al. Blood 123: 346-355 (2014) 
Ezinne CC, et al. PLoS One 9: e87631 (2014)
Matsuura E, et al. J Neuropathol Exp Neurol 74: 2-14 (2015)
TS-M025HLA-A*24:02 survivin-2B Tetramer-PEKitamura H, et al. Urology 67: 955-959 (2006) 
Tsuruma T, et al. J Transl Med 6: 24 (2008)
Miyazaki A, et al. Cancer Sci. 102: 324-329 (2011)
Kameshima H, et al. Cancer Sci. 102: 1181-1187 (2011)
Kameshima H, et al. Cancer Sci. 104: 124-129 (2013)
Satomi F, et al. Int J Cancer Clin Res 2: 1-6 (2015, MBL)
Tanaka T, et al. Cancer Sci. 106: 18-24 (2015)
Tanaka T, et al. Clin Dev Immunol. 2013;2013:262967. doi: 10.1155/2013/262967

 HLA-B*07:02 Citations

Product CodeAllelePublications
TB-0025-1TB-0025-2HLA-B*07:02 CMV pp65 Tetramer-TPRVTGGGAMOdumade OA, et al. J Exp Med 209: 471-478 (2012 BCI)

HLA-B*08:01 Citations

Product CodeAllelePublications
TB-0026-1TB-0026-2HLA-B*08:01 CMV IE1 Tetramer ELRRKMMYMOdumade OA, et al. J Exp Med 209: 471-478 (2012 BCI)
TS-M123HLA*-B08:01 EBV EBNA3A Tetramer-FLRGRAYGLCellerai C, et al. J Virol 84: 3868–3878 (2010 BCI)

 HLA-B*35:01 Citations

Product CodeAllelePublications
TB-0027-1, TB0027-2HLA-B*35:01 CMV pp65 Tetramer-IPSINVHHYOdumade OA, et al. J Exp Med 209: 471-478 (2012 BCI)

H-2Db Citations

Product CodeAllelePublications
TS-M502H-2Db Influenza NP Tetramer-PENakamura R, et al. J. Virol. 84: 5574-5582 (2010)
Takada K, et al. Nat Immunol 16: 1069–1076 (2015, MBL)
TS-M512H-2Db LCMV gp33 (C9M) Tetramer-KAVYNFATMMumprecht S, et al. Blood 113: 4681-4689 (2009, BCI) 
Ohyagi H, et al. Immunity 39: 584-598 (2013)
TS-M518H-2Db CEA Tetramer-EAQNTTYL-PE Hodge JW, et al. J Immunol 174: 5994-6004 (2005, BCI) 
Kudo-Saito C, et al. Clin Cancer Res 11: 2416-2426 (2005, BCI)
Garnett CT, et al. Clin Cancer Res 14: 3536–3544 (2008, BCI)
Loisel-Meyer S, et al. Mol Cancer Ther 8: 692–702 (2009, BCI) 
TS-M524H-2Db HY Uty Tetramer-WMHHNMDLI-PECheung K, et al PNAS 112: E5815-E5824 (2015, MBL) 
TS-M539-1H-2Db SV40 large T Ag 206-215 Tetramer-SAINNYAQKLBunse M, et al. Mol Ther 22: 1983-1991 (2014, BCI)
TS-M546H-2Db gp100 Tetramer-EGSRNQDWL-PEBetts MR, et al. J Immunol 172: 6407-6417 (2004, BCI) 
Akiyama Y, et al. J. Transl. Med. 3: 4-13 (2005)
Jalili A, et al. Blood 106: 3538-3545 (2005)
Miyagawa N, et al. Oncology 70: 54-62 (2006)
Kozako T, et al. J. Immunol. 177: 5718-5726 (2006)
Santomasso BD, et al. PNAS 104: 19073-19078 (2007 BCI) 
Akimoto M, et al. J. Med Virol. 79: 977-86 (2007)
Harao M, et al. Int J Cancer 123: 2616-2625 (2008) 
Tsukahara T, et al. Cancer Sci. 99: 368-375 (2008)
Wakabayashi A, et al. J. Immunol.180: 4000-4010 (2008)
Suemori K, et al. J. Gen. Virol. 90: 1806-1811 (2009) 
Tsukamoto T, et al. J. Virol. 83: 9339-9346 (2009) 
Akiyama Y, et al. Anticancer Res. 29: 647-655 (2009)
Yoshizaki M, et al. Blood 114: 1518-1527 (2009) 
Takatsuka N, et al. Int. Immunol. 21: 1089-1100 (2009)
Kobayashi E, et al. Nature Med 19: 1542–1546 (2013)
Suzuki H, et al. J Transl Med 11: 97 (2013)
Tomita Y, et al. OncoImmunology 3: e28100 (2014)
Imamura Y, et al. PLoS ONE 11: e0152384 (2016)

 H-2Kb Citations

Product CodeAllelePublications
TS-M008-1H-2Kb Negative Tetramer-PEAsano J, et al. J Immunol 184: 736-745 (2010)
Wakita D, et al. Int Immunol 18: 425-434 (2006)
Chamoto K, et al. Cancer Res 66: 1809-1817 (2006)
Fujimura T, et al. Eur J Immunol 36: 3371-3380 (2006)
TS-M507H-2Kb MuLV p15E Tetramer-KSPWFTTLGarnett CT, et al. Clin Cancer Res 14: 3536–3544 (2008, BCI)
Quetglas JI, et al. J Immunol 190: 2994-3004 (2013, BCI)
Cash H, et al. Oncotarget 6: 36400–36417 (2015)
Melero I, et al. Cancer Res 75: 497-507 (2015, BCI)
TS-M541, TS-M542, TS-M543H-2Kb OVA TetramerTeramoto K, et al. Cancer Res. 63: 7920-7925 (2003)
Li W, et al. Infect. Immun. 72: 7005-7011 (2004)
Yajima T, et al. J. Immunol. 174: 3590-3597 (2005)
Taneichi M, et al. J. Immunol. 177: 2324-2330 (2006)
Wakita D, et al. Int. Immunol. 18: 425-434 (2006)
Chamoto K, et al. Cancer Res. 66: 1809-1817 (2006)
Saito K, et al. J. Immunol. 176: 2496-2504 (2006)
Yokouchi H, et al. Cancer Sci. 97: 148-154 (2006) 
Yajima T, et al. J. Immunol. 176: 507-515 (2006) 
Nabekura T, et al. Molecular Therapy 13: 301–309 (2006)
Li W, et al. J Immunol 178: 4482-4488 (2007)
Zhang Y, et al. Int Immunol 19: 151-161 (2007)
Kumar H, et al. J Immunol 180: 683-687 (2008)
Wakabayashi A, et al. J Immunol 180: 4000-4010 (2008)
Tang C, et al. J Leukoc Biol 86: 187-194 (2009)
Kijima M, et al. J Immunol 182: 3566-3572 (2009)
Senju S, et al. Stem Cells 27: 1021-31 (2009)
Takeshima T, et al. Cancer Res 70: 2697-2706 (2010)
Asano J, et al. J Immunol 184: 736-745 (2010)
Kuwada E, et al. Anticancer Res 31: 881-891 (2011) 
Kurachi S, et al. J Exp Med 208: 1605-1620 (2011)
Yanai H, et al. PNAS 108: 11542-11547 (2011)
Fukaya T, et al. PNAS 109: 11288-11293 (2012, MBL) 
Tsukamoto H, et al. Cancer Immunology 1: 64-76 (2013) 
Kimura K, et al. Infect Immun 81: 3825-3834 (2013) 
Yamazaki C, et al. J Immunol 190: 6071-6082 (2013)
Shimizu K, et al. J Immunol 190: 5609-5619 (2013)
Kobiyama K, et al. PNAS 111: 3086-3091 (2014)
Ito M, et al. PLoS ONE 9: e110425 (2014, MBL)
Sasaki K, et al. Nat. Commun. 6: 7484 (2015, MBL)
Hanson MC, et al. Clin Invest 125: 2532-2546 (2015, MBLI)
Rapaport AS, et al. Immunity 43:1112-1124 (2015, MBL)
Toyota H, et al. Oncol Rep 33: 292-296 (2015, MBL)
Takada K, et al. Nat Immunol 16: 1069–1076 (2015, MBL)
Ito D, et al. J Immunol 195: 934-943 (2015, MBL) 
Seregin SS, et al. J Immunol 195: 1112-1120 (2015, MBLI) 
Pearce VQ, et al. J Immunol 195: 3206-3217 (2015, MBLI)
Eikawa S, et al. PNAS 112: 1809-1814 (2015, MBL) 
Fu C, et al. PNAS 112: 2823-2828 (2015, MBLI) 
Kamimura D, et al. Int Immunol 28: 117-126 (2016, MBL)

H-2Kd Citation

Product CodeAllelePublications
TS-M503H-2Kd Listeria LLO Tetramer-GYKDGNEYI Ozawa Y, et al. Am. J. Respir. Cell Mol. Biol. 41: 440-448 (2009)
Hayashi T, et al. J. Immunol. 182: 6360-6368 (2009)

I-Ab Citation

Product CodeAllelePublicatiions
TS-M707-1I-Ab ESAT-6 1-20 Tetramer-PE Liao T-YA, et al. PLoS ONE 10: e0145833 (2015, MBL) 

Mamu-A*01 Citations

Product CodeAllelePublications
T03004T03005T03004bMamu-A*01 SIV gag-Tetramer-CTPYDINQM 
Cecchinato V, et al. J. Immunol. 180: 5439-5447 (2008)
Jennifer N. Rainho JN, et al. J Virol 89: 10625-10636 (2015, MBL)

Anti-Mouse CD8 Citation

Product CodeAllelePublications
D271-4Anti-Mouse CD8 (clone KT15)Asano J, et al. J. Immunol. 184: 736-745 (2010)
Kayamuro H, et al. J. Virol. 84: 12703-12712 (2010)
Nobuoka D, et al. Cancer Immunol Immunother 62:639–652 (2013)
Ohyagi H, et al. Immunity 39: 584-598 (2013) 
Cash H, et al. Oncotarget 6: 36400–36417 (2015)
Toyota H, et al. Oncol Rep 33: 292-296 (2015)
Kamimura D, et al. Int Immunol 28: 117-126 (2016, MBL) 

Mouse CD1d Citation

Product CodeAllelePublications
TS-MCD-1Mouse CD1d Tetramer-PEYoshiga Y, et al. Clin Exp Immunol. 164: 236–247 (2011) 
Horikoshi M, et al. PLoS One 7: e51215 (2012)
Nakamura T, et al. J Control Release 171: 216–224 (2013)
Sekiya T, et al. Nat Immunol 14: 230–237 (2013) 
Adachi K, et al. PLoS One 9: e96042 (2014)

IMMUNOCYTO Citation

Product CodeAllelePublications
4844IMMUNOCYTO CD107a Detection KitSabouri AH, et al. Blood 112: 2411-2420 (2008)
PLOS ONE 2014 DOI: 10.1371/journal.pone.0087631

 QuickSwitch Citations

Product CodeAllelePublications
TB-7300-K1TB-7300-K2TB-7300-K4TB-7301-K1TB-7301-K2TB-7301-K4HLA-A*02:01Marc C Delcommenne, Olga Hrytsenko, Cynthia Tram, Genevieve Weir and Marianne M. Stanford (2017) The QuickSwitch HLA-A*02:01 Tetramer Kit can be used for determing the biological activity of a cancer vaccine. J Immunol, 198 (1 Supplement) 79.27;KulaT.,Dezfulian, M. H. Wang, C.I., Abdelfattah, N.S., Hartman, Z.C. Wucherpfennig, K.W.,….Elledge, S.J. (2019). T-Scan: A Genome-wide Method for the Systematic Discovery of T Cell Epitopes, Cell, 178(4). DOI: 10.1016/j.cell.2019.07.009 Christof C. Smith, Shengjie Chai, Amber R. Washington, Samuel J. Lee, Elisa Landoni, Kevin Field, Jason Garness, Lisa M. Bixby, Sara R. Selitsky, Joel S. Parker, Barbara Savoldo, Jonathan S. Serody, and Benjamin G. Vincent (2019) Machine-Learning Prediction of Tumor Antigen Immunogenicity in the Selection of Therapeutic Epitopes dok: 10.1158/2326-6066.CIR-1900155
TB-7302-K1TB-7302-K4, TB-7303-K4HLA-A*24:02Marc C Delcommenne, Olga Hrytsenko, Cynthia Tram, Genevieve Weir and Marianne M. Stanford (2017) The QuickSwitch HLA-A*02:01 Tetramer Kit can be used for determing the biological activity of a cancer vaccine. J Immunol, 198 (1 Supplement) 79.27;KulaT.,Dezfulian, M. H. Wang, C.I., Abdelfattah, N.S., Hartman, Z.C. Wucherpfennig, K.W.,….Elledge, S.J. (2019). T-Scan: A Genome-wide Method for the Systematic Discovery of T Cell Epitopes, Cell, 178(4). DOI: 10.1016/j.cell.2019.07.009 Christof C. Smith, Shengjie Chai, Amber R. Washington, Samuel J. Lee, Elisa Landoni, Kevin Field, Jason Garness, Lisa M. Bixby, Sara R. Selitsky, Joel S. Parker, Barbara Savoldo, Jonathan S. Serody, and Benjamin G. Vincent (2019) Machine-Learning Prediction of Tumor Antigen Immunogenicity in the Selection of Therapeutic Epitopes dok: 10.1158/2326-6066.CIR-1900155
TB-7304-K1TB-7304-K2TB-7304-K4HLA-A*11:01Marc C Delcommenne, Olga Hrytsenko, Cynthia Tram, Genevieve Weir and Marianne M. Stanford (2017) The QuickSwitch HLA-A*02:01 Tetramer Kit can be used for determing the biological activity of a cancer vaccine. J Immunol, 198 (1 Supplement) 79.27;KulaT.,Dezfulian, M. H. Wang, C.I., Abdelfattah, N.S., Hartman, Z.C. Wucherpfennig, K.W.,….Elledge, S.J. (2019). T-Scan: A Genome-wide Method for the Systematic Discovery of T Cell Epitopes, Cell, 178(4). DOI: 10.1016/j.cell.2019.07.009 Christof C. Smith, Shengjie Chai, Amber R. Washington, Samuel J. Lee, Elisa Landoni, Kevin Field, Jason Garness, Lisa M. Bixby, Sara R. Selitsky, Joel S. Parker, Barbara Savoldo, Jonathan S. Serody, and Benjamin G. Vincent (2019) Machine-Learning Prediction of Tumor Antigen Immunogenicity in the Selection of Therapeutic Epitopes dok: 10.1158/2326-6066.CIR-1900155
TB-7400-K1TB-7400-K2TB-7400-K4TB-7401-K1TB-7401-K2TB-7401-K4H-2KbMarc C Delcommenne, Olga Hrytsenko, Cynthia Tram, Genevieve Weir and Marianne M. Stanford (2017) The QuickSwitch HLA-A*02:01 Tetramer Kit can be used for determing the biological activity of a cancer vaccine. J Immunol, 198 (1 Supplement) 79.27;KulaT.,Dezfulian, M. H. Wang, C.I., Abdelfattah, N.S., Hartman, Z.C. Wucherpfennig, K.W.,….Elledge, S.J. (2019). T-Scan: A Genome-wide Method for the Systematic Discovery of T Cell Epitopes, Cell, 178(4). DOI: 10.1016/j.cell.2019.07.009 Christof C. Smith, Shengjie Chai, Amber R. Washington, Samuel J. Lee, Elisa Landoni, Kevin Field, Jason Garness, Lisa M. Bixby, Sara R. Selitsky, Joel S. Parker, Barbara Savoldo, Jonathan S. Serody, and Benjamin G. Vincent (2019) Machine-Learning Prediction of Tumor Antigen Immunogenicity in the Selection of Therapeutic Epitopes dok: 10.1158/2326-6066.CIR-1900155